We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On April 8, 2011, the Delaware Court of Chancery handed down a decision (Meso Scale Diagnostics, LLC v. Roche Diagnostics GMBH, C.A. No. 5589-VCP (Del. Ch. April 8, 2011)) that might impact how M&A deals are structured and what third party consents must be obtained
A recent decision by the Delaware Supreme Court in Lyondell Chemical Co. v. Ryan made several important clarifications about the nature of the fiduciary duties that corporate directors owe in connection with the sale of Delaware corporations
